Cardiologycardiogenic shockdobutamine
Cardiogenic Shock Care Still Varies Widely Across CICUs, Especially in the Choice of Inodilators
By MedXY|May 19, 2026
A large CCCTN analysis found major institutional and patient-level variation in vasoactive drug selection for cardiogenic shock, highlighting persistent evidence gaps in choosing dobutamine, milrinone, and other vasoactive therapies.